The detection and prevention of unintentional consumption of DOx and 25x‐NBOMe at Portugal's Boom Festival
Daniel Martins, Monica J Barratt, Cristiana Vale Pires, Helena Carvalho, Mireia Ventura, Iván Fornís Espinosa, Helena Valente
Human Psychopharmacology: Clinical and Experimental May 1, 2017 DOI: 10.1002/hup.2608 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational study Peer reviewed |
|---|---|
| Sample size | 245 |
| Population | Attendees of Boom Festival 2014 who submitted drug samples for testing |
| Keywords | Drug Test biology Consumption sociology Boom Advertising Service business Internet privacy Marketing |
| Citations | 76 |
| Key findings | Only 67.3% of alleged LSD samples contained LSD, and 74.2% of users who received unexpected results reported they did not intend to consume the drug they actually had. |
Abstract
Abstract Objective This paper describes the misrepresentation of LSD at Portugal's Boom Festival 2014 and the prevention of unintentional consumption of DOx and 25x‐NBOMe among LSD consumers attending a drug‐checking service.
Methods: Two hundred forty‐five drug samples expected to contain LSD were submitted to the drug‐checking service for chemical analysis. One hundred ten post‐test questionnaires were successfully matched with test results.
Results: About 67.3% of the alleged LSD samples tested contained only LSD; 0.8% contained LSD combined with adulterants; 24.1% did not contain LSD but did contain another psychoactive substance, including 11.4% that were 2,5‐dimethoxyamphetamine derivatives and 9.8% that were N ‐benzyl‐2,5‐dimethoxyphenethylamine derivatives; and no psychoactive substance was detected in 7.8%. The majority of service users who received unexpected test results regarding their alleged LSD (74.2%) reported that they did not intend to consume the drug. Following dissemination of alerts on day 2, a larger than expected proportion of all tests conducted were for LSD, when comparing the 2014 festival to 2012, where no such alert was disseminated.
Conclusions: Although these results support the provision of integrated drug‐checking services in party settings, evidence of their utility and effectiveness would be improved through future research incorporating more robust measures of outcomes following provision of drug‐checking results.
Citations in the library
Cited by 18
- New psychoactive substances (NPS) and serotonin syndrome onset: A systematic review. Experimental Neurology May 1, 2021
- A qualitative descriptive analysis of effects of psychedelic phenethylamines and tryptamines Human Psychopharmacology: Clinical and Experimental 2020
- American Trip The MIT Press eBooks July 14, 2020
- Prevalence and epidemiological associates of novel psychedelic use in the United States adult population. Journal of Psychopharmacology September 1, 2019
- Para-Halogenation Affects Monoamine Transporter Inhibition Properties and Hepatocellular Toxicity of Amphetamines and Methcathinones Frontiers in Pharmacology April 24, 2019
and 13 more in the library
Cites 12
- Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology July 1, 2008
- Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases The Journal of Nervous and Mental Disease March 4, 2014
- 2,5-Dimethoxy-4-methyl-amphetamine (STP): A New Hallucinogenic Drug Science November 3, 1967
- New psychoactive substances as adulterants of controlled drugs. A worrying phenomenon? Drug Testing and Analysis 2014
- 2C-I-NBOMe, an "N-bomb" that kills with "Smiles". Toxicological and legislative aspects. Drug and Chemical Toxicology 2015
and 7 more in the library